Support throughout the entire process, including identification of strengths, weaknesses, and potential for improvements.
Providing valuable insights and strategic guidance in the clinical research landscape
Tailored consulting services to address the unique needs of each client
Passion for providing solutions that enhance operational excellence and overall trial success
Hello there! I'm Megan Liles, a seasoned professional with a rich and diverse background in the clinical research industry. My journey began in 1997 as a Research Coordinator in Detroit, MI, where I worked to recruit and follow persons living with HIV/AIDS into clinical trials. This was during a time when treatment options were significantly limited - the resilience and hope exhibited by these patients left an indelible mark on my professional outlook.
My career path has been a dynamic evolution, taking me from the role of Clinical Research Associate to Clinical Team Lead and Project Manager. With each step, I delved deeper into the intricacies of clinical operations, eventually assuming roles such as Director of Project Management, Global Head of Clinical Operations and Project Delivery, and then Vice President roles in Operational Strategy and Clinical Operations.
It has been my expertise in operational strategy and clinical trial management that have been a cornerstone of my career. I have led initiatives across CROs and pharma companies focused on applying innovative strategies and leveraging technology to optimize patient recruitment and engagement in clinical trials. In recent years, my focus has honed in on oncology trials, specifically in biomarker-driven and cell therapies.
Drawing from direct interactions with patients and my roots in a small US Midwest town, I've witnessed firsthand the challenges faced by individuals who must travel extensive distances to access critical clinical trials. This personal experience has ignited my passion for making clinical trials more accessible to patients and making them true stakeholders.
With a career spanning diverse roles, I am excited about the prospects of continuing to shape the landscape of clinical trials, ensuring that putting patients first remains at the heart of our endeavors.